Placeholder canvas

Raw Pressery raises Rs 33.5 crore in debt and equity

Date:

Raw Pressery, an organic cold-pressed juices and healthy drinks brand, has raised Rs 33.5 crore from Alteria Capital. The investment includes both equity and venture debt from Alteria Capital, a first-time move for Mumbai-based venture debt firm.

The existing investors in Rakyan Beverages, the company which owns the brand of includes, Sequoia Capital, DSG Consumer Partners and Saama Capital. The start-up had raised nearly Rs 150 crore, prior to the latest funding round.

ALSO READ: Applying to the UN, EU, WB without success? This start-up can help you

Founded in 2013 by Anuj Rakyan, Raw Pressery plans to use the capital for launching new categories like nut milk, ready-to-consume soups and probiotic dairy drinks.

Alteria has previously invested in ready-to-cook food firm Fingerlix, online learning platform Toppr Technologies and fashion startup Universal Sportsbiz.

Raw Pressery products currently sells through retail outlets like Reliance Retail, Nature’s Basket (Godrej), D-Mart and on online platforms such as Amazon and BigBasket, among others.

The start-up forayed into Dubai, Abu Dhabi and Doha last year.

Click here for Latest News updates and viral videos on our AI-powered smart news genie

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

NewsMobile Morning Brief

Congress Party Office In Amethi Vandalised The Congress party office...

Congress Party Office In Amethi Vandalised

Amethi: The Congress party office in Uttar Pradesh's Amethi...

IPL 2024: Chasing Mounting Total, LSG Succumb To KKR Bowling Attack, Concede 98-Run Defeat

With the massive against the Lucknow-based franchise, KKR moved to the top of the table with 16 points and a net run rate of +1.453

Israel Shuts Down Local Al Jazeera Offices In The Country 

Al Jazeera said the accusation that it threatened Israeli security was a “dangerous and ridiculous lie” that put its journalists at risk